Deutsche Bank Aktiengesellschaft Raises BioNTech (NASDAQ:BNTX) Price Target to $150.00
BioNTech (NASDAQ:BNTX – Free Report) had its price objective hoisted by Deutsche Bank Aktiengesellschaft from $95.00 to $150.00 in a research note released on Thursday morning, Benzinga reports. Deutsche Bank Aktiengesellschaft currently has a buy rating on the stock. Several other brokerages have also commented on BNTX. TD Cowen decreased their price target on BioNTech […]
23 Sep 08:17 · The Markets Daily